Becton, Dickinson and Company (BDX)
|Net Income (ttm)||1.51B|
|Trading Day||March 5|
|Day's Range||240.95 - 247.61|
|52-Week Range||196.42 - 283.99|
Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock?
When the market is expensive and overbought like the current one is, it is very important to stay with companies that not only have solid earnings potential but also have upcoming catalysts th...
BD Acquires GSL Solutions, Inc., Broadening Medication Management Offerings for Retail, Outpatient Pharmacy Settings
FRANKLIN LAKES, N.J., March 4, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired GSL Solutions, ...
The new president has a lot of work to do, and many companies are likely to benefit from some of his priorities.
Leading medical device manufacturer Becton, Dickinson & Co. (NYSE:BDX), or BD, recently reported earnings results that showed the company greatly benefited from Covid-19-related sales. BD prov...
BD (BDX) plans to develop a lateral flow antigen test and pair it with the Scanwell Health mobile app via the latest partnership.
It's possible that some stocks could fly higher with the policy change being considered by the Biden administration.
Health care companies may not be at the front of mind when thinking of stocks with dividends, but these three are winners. The post 3 High-Quality Health Care Companies With Recession-Proof Di...
The dental equipment market seems ready to grow as it continues to recover from the COVID-19 pandemic slump, making it prudent to look at names like Henry Schein (HSIC) and McKesson (MCK)
BD's (BDX) new test has the capability to detect SARS-CoV-2 and Influenza A+B in a single test.
Becton Dickinson Lauded by Frost & Sullivan for Enhancing Patient Experience with Its BD Intevia™ Autoinjector
The solution leverages a modular platform technology that allows rapid customization, optimizing time and cost for pharma companies SANTA CLARA, Calif., Feb. 16, 2021 /PRNewswire/ -- Based on ...
FRANKLIN LAKES, N.J., Feb. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the fol...
The FDA has granted Emergency Use Authorization (EUA) to Becton Dickinson and Co's (NYSE: BDX) new molecular test for both SARS-CoV-2 and Influenza A+B. The new test has also received a CE mar...
BD Announces Emergency Use Authorization, CE Mark for Combination Molecular Diagnostic to Detect SARS-CoV-2, Influenza A+B in Single Test
FRANKLIN LAKES, N.J., Feb. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Adm...
Covid-19 testing drives Becton Dickinson Q1 revenue growth
Medical devices company Becton Dickinson beat the top and bottom line in its first-quarter results. Covid-19 testing helped drive its revenue growth to $867 million.
Becton Dickinson (BDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Selling shovels doesn't get stale if the gold rush never ends.
Each of Becton Dickinson's (BDX) core units witnesses strong revenue growth in the fiscal first quarter.
Becton Dickinson (BDX) delivered earnings and revenue surprises of 44.90% and 0.13%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
FRANKLIN LAKES, N.J., Feb. 4, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $5.315 bill...
First-of-its-Kind Randomized Clinical Trial Published in "The Lancet Infectious Diseases" Outlines Potential New Standard-Setting Best Practices for Peripheral IV Catheters
FRANKLIN LAKES, N.J., Feb. 2, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that new clinical data have foun...
Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BD's (BDX) first-quarter fiscal 2021 results are likely to reflect strong year-over-year growth in revenues from assays in its Life Sciences segment.
Update in Lawsuit for Investors in shares of Becton, Dickinson and Company (NYSE: BDX) announced by Shareholders Foundation
SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: BDX shares. Investors, who purchased NYSE: BDX...
FRANKLIN LAKES, N.J., Jan. 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president...
FRANKLIN LAKES, N.J., Jan. 25, 2021 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payabl...
As of late, it has definitely been a great time to be an investor in Becton, Dickinson and Company (BDX).
Healthcare aristocrats benefit from significant medical device contributions. By and large these healthcare aristocrats share favorable quant metrics on Seeking Alpha, albeit with significant ...
The Department of Health and Human Services (HHS) promises over $22 billion of funding.
The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader (Podcast Transcript)
Welcome to Alpha Trader. We have a special double bill today in honor of wildcard weekend coming up on the show. Eddy Elfenbein of Crossing Wall Street giving us his top five new stocks for 20...
BD (BDX) projects its fiscal Q1 revenues to surge from the year-ago figure, primarily on the back of high demand for its COVID-19 diagnostic tests
The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.
Final Trades: Zynga, Becton Dickinson & more
The "Halftime Report" investment committee give their top picks to watch for the second half.
Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader
This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with LPL Financial's Ryan Detrick and Eddy Elfenbein, editor of the Crossing Wall Street blog and portfol...
Shares of Becton Dickinson & Co. rallied 2.3% in premarket trading Tuesday, after the medical technology company provided an upbeat outlook for its first quarter. For the quarter ended Dec. 31...
BD Provides Updates To Its Fiscal 2021 Financial Outlook And Intends To Comment On Its Preliminary First Fiscal Quarter Revenue Performance During Today's Webcast At The 39th Annual J.P. Morgan Healthcare Conference
FRANKLIN LAKES, N.J., Jan. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported, preliminary unaudited financial...
Here we discuss four dividend-paying value stocks, MCK, CAH, BDX and HRC, which though trading cheap now, have solid chances of a rebound in the second half of 2021.
The Covid-19 vaccine rally isn't just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.
In previous articles I analyzed Abbott and Medtronic. BD is their somewhat smaller peer, and a company I own.
FRANKLIN LAKES, N.J., Dec. 22, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 39t...
Large-cap stocks have seen wildly varying performance in 2020. And in 2021, these four names should be among the group's best.
The health care sector is considered a defensive sector as people will seek out treatment for illness and aliments regardless of the status of the economy. Many companies in this sector litera...
When it comes to Covid-19, Becton, Dickinson and Co. (NYSE:BDX) hasn't gained the attention of vaccine developers like Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ), nor those compan...
FRANKLIN LAKES, N.J., Dec. 9, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced publication of the results from ...
Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock?
Let's see if Becton, Dickinson (BDX) stock is a good choice for value-oriented investors right now from multiple angles.
All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. An average increase of 4.06% and a median increase of 3.64%.
BD (BDX) is set to improve its pre-fillable syringe-manufacturing ability with its expansion and upgrade plans.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; in... [Read more...]
Medical Instruments & Supplies
|IPO Date |
Apr 23, 1962
|Stock Exchange |
|Ticker Symbol |
In 2020, BDX's revenue was $17.12 billion, a decrease of -1.00% compared to the previous year's $17.29 billion. Earnings were $874.00 million, a decrease of -29.17%.
According to 18 analysts, the average rating for BDX stock is "Buy." The 12-month stock price forecast is 281.57, which is an increase of 14.25% from the latest price.